Marion Jurk

3.5k total citations
30 papers, 2.0k citations indexed

About

Marion Jurk is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Marion Jurk has authored 30 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 13 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Marion Jurk's work include Immune Response and Inflammation (21 papers), Immune Cell Function and Interaction (14 papers) and RNA Interference and Gene Delivery (8 papers). Marion Jurk is often cited by papers focused on Immune Response and Inflammation (21 papers), Immune Cell Function and Interaction (14 papers) and RNA Interference and Gene Delivery (8 papers). Marion Jurk collaborates with scholars based in Germany, United States and Canada. Marion Jurk's co-authors include Jürgen Vollmer, Arthur Μ. Krieg, Christian Schetter, Alexandra Forsbach, Risini D. Weeratna, Heather L. Davis, Paul Payette, Ulrike Samulowitz, Ming Liu and Stefan Bauer and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Marion Jurk

30 papers receiving 1.9k citations

Peers

Marion Jurk

IMMUN

EPIDE

MICRO

Bithi Chatterjee Switzerland

Susanne Hausmann Germany

Kanako L. Lewis United States

Juan R. de los Toyos Spain

Anna‐Lena Spetz Sweden

Katja Mohrs United States

Elodie Belnoue Switzerland

Karen J. Mackenzie United Kingdom

Prafullakumar Tailor United States

E Claassen Netherlands

Bithi Chatterjee Switzerland

Marion Jurk

1.9k ×1.3

IMMUN

591 ×0.9

314 ×1.4

EPIDE

58 ×0.3

309 ×1.6

MICRO

Citations per year, relative to Marion Jurk Marion Jurk (= 1×) peers Bithi Chatterjee

Countries citing papers authored by Marion Jurk

Since Specialization

Citations

This map shows the geographic impact of Marion Jurk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Jurk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Jurk more than expected).

Fields of papers citing papers by Marion Jurk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Jurk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Jurk. The network helps show where Marion Jurk may publish in the future.

Co-authorship network of co-authors of Marion Jurk

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Jurk. A scholar is included among the top collaborators of Marion Jurk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Jurk. Marion Jurk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aleksandrova, Krasimira, Christoph Priesner, Anette Melk, et al.. (2019). Functionality and Cell Senescence of CD4/ CD8-Selected CD20 CAR T Cells Manufactured Using the Automated CliniMACS Prodigy® Platform. Transfusion Medicine and Hemotherapy. 46(1). 47–54. 42 indexed citations

Römmler, Franziska, Anna Waldhuber, Tina Müller, et al.. (2015). Guanine-Modified Inhibitory Oligonucleotides Efficiently Impair TLR7- and TLR9-Mediated Immune Responses of Human Immune Cells. PLoS ONE. 10(2). e0116703–e0116703. 27 indexed citations

Jurk, Marion, et al.. (2015). RNA-based, transient modulation of gene expression in human haematopoietic stem and progenitor cells. Scientific Reports. 5(1). 17184–17184. 10 indexed citations

Forsbach, Alexandra, Christian Müller, Toan B. Nguyen, et al.. (2012). Negative Regulation of the Type I Interferon Signaling Pathway by Synthetic Toll-Like Receptor 7 Ligands. Journal of Interferon & Cytokine Research. 32(6). 254–268. 7 indexed citations

Jurk, Marion, et al.. (2011). Immunostimulatory Potential of Silencing RNAs Can Be Mediated by a Non-Uridine-Rich Toll-Like Receptor 7 Motif. Oligonucleotides. 1174455991–1174455991. 1 indexed citations

Forsbach, Alexandra, et al.. (2011). Impact of delivery systems on siRNA immune activation and RNA interference. Immunology Letters. 141(2). 169–180. 12 indexed citations

Hackstein, Holger, et al.. (2011). The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation. Cellular Immunology. 271(2). 401–412. 44 indexed citations

Jurk, Marion, et al.. (2011). Immunostimulatory Potential of Silencing RNAs Can Be Mediated by a Non-Uridine-Rich Toll-Like Receptor 7 Motif. Nucleic Acid Therapeutics. 21(3). 201–214. 17 indexed citations

Jurk, Marion, Alexandra Forsbach, Risini D. Weeratna, et al.. (2009). Sequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responses. International Immunology. 21(5). 607–619. 29 indexed citations

10.

Forsbach, Alexandra, Christian Müller, Ulrike Samulowitz, et al.. (2008). Identification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses. The Journal of Immunology. 180(6). 3729–3738. 248 indexed citations

11.

Jurk, Marion & Jürgen Vollmer. (2007). Therapeutic Applications of Synthetic CpG Oligodeoxynucleotides as TLR9 Agonists for Immune Modulation. BioDrugs. 21(6). 387–401. 71 indexed citations

12.

Jurk, Marion, et al.. (2006). Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T‐rich phosphorothiate oligodeoxynucleotides. European Journal of Immunology. 36(7). 1815–1826. 69 indexed citations

13.

Jurk, Marion, et al.. (2006). Structure–Activity Relationship Studies on the Immune Stimulatory Effects of Base‐Modified CpG Toll‐Like Receptor 9 Agonists. ChemMedChem. 1(9). 1007–1014. 29 indexed citations

14.

Vollmer, Jürgen, Claudia Schmitz, Svetlana Hamm, et al.. (2005). Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. The Journal of Experimental Medicine. 202(11). 1575–1585. 406 indexed citations

15.

Vollmer, Jürgen, Jan Stenvang, Eugen Uhlmann, et al.. (2004). Modulation of CpG Oligodeoxynucleotide-Mediated Immune Stimulation by Locked Nucleic Acid (LNA). Oligonucleotides. 14(1). 23–31. 43 indexed citations

16.

Vollmer, Jürgen, Risini D. Weeratna, Marion Jurk, et al.. (2004). Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll‐like receptor 9 dependent T helper type 2 biased immune stimulation. Immunology. 113(2). 212–223. 116 indexed citations

17.

Jurk, Marion, Bernhard Noll, Eugen Uhlmann, et al.. (2004). C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level. Immunobiology. 209(1-2). 141–154. 62 indexed citations

18.

Vollmer, Jürgen, Risini D. Weeratna, Paul Payette, et al.. (2003). Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. European Journal of Immunology. 34(1). 251–262. 481 indexed citations

19.

Jurk, Marion, et al.. (1999). Identification of COUP-TF as a Transcriptional Repressor of the c-mos Proto-oncogene. Journal of Biological Chemistry. 274(51). 36796–36800. 7 indexed citations

20.

Jurk, Marion, et al.. (1996). Characterization of the Single-Strand-Specific BPV-1 Origin Binding Protein, SPSF I, as the Hela Pur Factor. Nucleic Acids Research. 24(14). 2799–2806. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact